Principal Investigator
Richard Preston
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20210761
Clinical Trial Summary
An Open Label Phase 1 Study to Evaluate The Effect of Mild,
Moderate or Severe Hepatic Impairment on the Single Dose
Pharmacokinetics of PLN-74809
Phase
Phase I
Funding Agency/Sponsor
Industry
Disease
Other